Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125.70 EUR | -0.98% | -1.80% | -7.37% |
Sep. 09 | BEIERSDORF AG : Gets a Neutral rating from Bernstein | ZD |
Sep. 04 | Beiersdorf: partnership with American Macro Biologics | CF |
1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
22 | |||||||||
24 | |||||||||
17 | |||||||||
22 | |||||||||
- | |||||||||
14 | |||||||||
27 | |||||||||
11 | |||||||||
35 | |||||||||
40 | |||||||||
- | |||||||||
- | - | ||||||||
11 | |||||||||
6 | |||||||||
13 | |||||||||
22 | |||||||||
26 | |||||||||
7 | |||||||||
9 | |||||||||
- | - | ||||||||
Average | 19 | ||||||||
Weighted average by Cap. | 22 |
- Stock Market
- Equities
- BEI Stock
- Sector Beiersdorf
- Sector revisions